MBII - Marrone Bio Innovations, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.5600
-0.0200 (-1.27%)
At close: 4:00PM EDT

1.5600 0.00 (0.00%)
After hours: 4:00PM EDT

Stock chart is not supported by your current browser
Previous Close1.5800
Open1.6000
Bid1.5600 x 2200
Ask1.9100 x 3000
Day's Range1.5000 - 1.6000
52 Week Range1.1000 - 1.9900
Volume208,010
Avg. Volume122,214
Market Cap192.545M
Beta (3Y Monthly)-0.41
PE Ratio (TTM)N/A
EPS (TTM)-0.1870
Earnings DateAug 7, 2017 - Aug 11, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.14
Trade prices are not sourced from all markets
  • ACCESSWIRE

    The Micro-Cap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas

    Company lineup is filling up fast with 50 good names in the microcap markets, as well as some great private and Pre-IPO companies AUSTIN, TX / ACCESSWIRE / September 19, 2019 / The MicroCap Rodeo's inaugural ...

  • GlobeNewswire

    Marrone Bio Announces Closing of Pro Farm Technologies Acquisition

    Marrone Bio completed the acquisition of Pro Farm on September 13, 2019, for an agreed enterprise value of $31.8 million, including a combination of $6.2 million cash and 12.7 million shares of Marrone Bio stock paid to Pro Farm’s equity holders, debt holders and advisors in connection with the closing, as well as the opportunity for potential payment of a total of up to $7.5 million of additional shares of stock deliverable from 2021 through 2024 based on the achievement of agreed commercial milestones. As a result of the acquisition, Pro Farm became a wholly owned subsidiary of Marrone Bio.

  • 5 things to know, and a chance to wear a superhero costume
    American City Business Journals

    5 things to know, and a chance to wear a superhero costume

    A sale price for the Citizen You might recall that the Citizen Hotel in downtown Sacramento was sold in July for the first time in four years, to Miami-based private equity firm Cambridge Landmark. What happens now with 301 Capitol Mall Now that the California Public Employees' Retirement System has dropped CIM Group as manager of the 301 Capitol Mall project, the future is uncertain for one of the region's biggest potential commercial developments.

  • Marrone Bio buys ag-tech assets from Florida company
    American City Business Journals

    Marrone Bio buys ag-tech assets from Florida company

    Davis biotechnology company Marrone Bio Innovations Inc. said it paid $2.5 million for two biologic product lines from Jet Harvest Solutions.

  • GlobeNewswire

    Marrone Bio Acquires Jet Ag and Jet Oxide Product Lines; Significantly Expands Opportunity in Agricultural Bioprotection Market

    Marrone Bio Innovations Inc. (MBII), a leading developer of bio-based products for pest management and plant health, has acquired from Jet Harvest Solutions all rights and assets to the Jet Ag and Jet Oxide product lines.  Jet Ag and Jet Oxide are broad-spectrum products used both for control of fungal and bacterial diseases and as disinfectants.

  • Bee Vectoring, led by Sacramento executive, wins EPA approval for bee-delivered fungicide
    American City Business Journals

    Bee Vectoring, led by Sacramento executive, wins EPA approval for bee-delivered fungicide

    Bee Vectoring Technology, led by local ag-tech executive Ashish Malik, won approval from the U.S. Environmental Protection Agency for its biological fungicide that's delivered to plants by bees.

  • Thomson Reuters StreetEvents

    Edited Transcript of MBII earnings conference call or presentation 8-Aug-19 8:30pm GMT

    Q2 2019 Marrone Bio Innovations Inc Earnings Call

  • Top Marijuana Stocks on the NASDAQ
    Investopedia

    Top Marijuana Stocks on the NASDAQ

    The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges. Learn about the marijuana stocks on the Nasdaq.

  • GlobeNewswire

    Marrone Bio Innovations CEO Dr. Pam Marrone Receives Innovation Award in Chemistry of Agriculture from the American Chemical Society

    DAVIS, Calif., Aug. 28, 2019 -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced.

  • GlobeNewswire

    Marrone Bio Innovations to Present at Upcoming Investor Conferences

    DAVIS, Calif., Aug. 28, 2019 -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant.

  • Easy Come, Easy Go: How Marrone Bio Innovations (NASDAQ:MBII) Shareholders Got Unlucky And Saw 77% Of Their Cash Evaporate
    Simply Wall St.

    Easy Come, Easy Go: How Marrone Bio Innovations (NASDAQ:MBII) Shareholders Got Unlucky And Saw 77% Of Their Cash Evaporate

    Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...

  • Fastest Growing Companies: Marrone Bio has ambitious plans for continued growth
    American City Business Journals

    Fastest Growing Companies: Marrone Bio has ambitious plans for continued growth

    This profile focuses on Marrone Bio Innovations Inc. The company ranked No. 26 on the Business Journal's list this year. See the full list here. Pam Marrone has big plans for her company, Marrone Bio Innovations Inc. “I would really like to be the largest biologicals company on the planet,” she said.

  • Zacks Small Cap Research

    MBII: Innovative financing and acquisition announced. Record second quarter revenue and continued margin expansion are positive.

    Marrone Bio (MBII) has announced a new financing that allows Marrone to convert existing warrants to equity as long as the stock price is over $1 a share. There are 41.7 million warrants with an exercise price of $1.00. There will be $26.6 million available from warrant conversion of existing warrants if it is needed.

  • Davis-based Marrone Bio to buy Finland ag-tech company
    American City Business Journals

    Davis-based Marrone Bio to buy Finland ag-tech company

    Davis-based Marrone Bio Innovations Inc. said Thursday it is buying Finland-based Pro Farm Technologies for $31.8 million.

  • GlobeNewswire

    Marrone Bio Innovations, Inc. Reports Second-Quarter and First-Half 2019 Financial Results

    Second Quarter 2019 Revenues Rose 22 Percent to $7.0 Million; First Half 2019 Revenues Increased 56 Percent to $15.7 Million Company Also Announces Pro Farm Acquisition to.

  • GlobeNewswire

    Marrone Bio announces transformative acquisition of Pro Farm Technologies in the $4.6 billion seed- and soil-treatment market

    Marrone Bio Innovations Inc. (MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has entered into a definitive purchase agreement to acquire Pro Farm Technologies OY, which will increase Marrone Bio’s market share and global platform in the $4.6 billion seed- and soil-treatment market. With the acquisition of Pro Farm, Marrone Bio will add proprietary nutrient and biostimulant technology and products for seed and foliar treatments to its portfolio.  This transaction also will give the company a significant opportunity to leverage an expanded global distribution network for all of MBI’s products.  Marrone Bio expects to benefit from partial-year sales in 2019 as a result of the transaction.  With historical gross margins significantly higher than Marrone Bio’s current product portfolio average, the Pro Farm acquisition is expected to be accretive to net income and cash flow from operations in 2020.

  • GlobeNewswire

    Marrone Bio announces financing facility to fund future operations and strategic acquisitions

    Marrone Bio Innovations Inc. (MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has established a $36.6 million financing facility with existing investors Ospraie Ag Science LLC, Ardsley Partners Renewable Energy Fund, L.P., and Ivan Saval through a right for Marrone Bio to call the exercise of the investors’ outstanding warrants at $1.00 per share. New warrants to purchase shares at a higher exercise price of $1.75 will be issued on a one-for-one basis along with every called share under the outstanding warrants. The company expects to draw upon the facility only as needed, and may draw on the facility at any time the company’s stock trades above $1.00 per share.

  • GlobeNewswire

    Marrone Bio Innovations to Report Second Quarter 2019 Results on Thursday, August 8th at 4:30 p.m. Eastern Time

    DAVIS, Calif., Aug. 02, 2019 -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of bio-based products for pest management and plant health, will release.

  • Zacks Small Cap Research

    MBII: Multiple applications of bio-insecticides provide additional control in both almonds and grapes. MBII enters partnership with Valagro.

    Marrone Bio Innovations (MBII) has entered into an agreement with Valagro S.p.A. [Spain] to collaborate on R&D efforts to integrate parts of Marrone's extensive microorganism library with Valagro's biostimulation (enhanced fertilizers) products. This is similar to the recently announced collaboration with Compass Minerals (CMP).

  • GlobeNewswire

    Marrone Bio Innovations and Valagro announce research collaboration

    Marrone Bio Innovations Inc. (the “Company” or “MBI”) (MBII), a leading developer of bio-based products for pest management and plant health, today announced that it has entered into a strategic partnership to collaborate on research and development efforts with Valagro S.p.A, a leader in the production and commercialization of biostimulants and specialty nutrients. The global, non-exclusive research collaboration will leverage a subset of Marrone Bio’s collection of 18,000 microorganisms in conjunction with Valagro’s biostimulant and plant nutrition products that enhance crop yield and quality.  Products resulting from this partnership have the potential to enhance a grower’s productivity and return on investment with plants that develop better root systems, grow with more vigor and thrive under harsher growing conditions.  Additonally, growers  of specialty crops would have the potential to produce higher quality fruit that matures more quickly.

  • Does Marrone Bio Innovations, Inc.'s (NASDAQ:MBII) CEO Salary Compare Well With Others?
    Simply Wall St.

    Does Marrone Bio Innovations, Inc.'s (NASDAQ:MBII) CEO Salary Compare Well With Others?

    Pam Marrone became the CEO of Marrone Bio Innovations, Inc. (NASDAQ:MBII) in 2006. First, this article will compare...

  • GlobeNewswire

    Marrone Bio Innovations’ BioUnite™ program offers new solutions to California growers

    Marrone Bio Innovations Inc. (the “Company” or “MBI”) (MBII), a leading developer of bio-based products for pest management and plant health, today announced that California almond and grape growers are gaining an edge as they address mid-season pest control issues through the implementation of the company’s novel BioUnite program. Marrone Bio launched BioUnite to provide growers with integrated pest management programs that harness the power of biology with the performance of chemistry resulting in a more efficient food production system that is affordable, sustainable, safe, and easy to use.

  • Zacks Small Cap Research

    MBII: Grandevo WDG approved for patent issuance

    By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT On June 25, 2019, Marrone Bio Innovations (NASDAQ:MBII) received notice that the major claims covering composition and method of manufacture ...

  • GlobeNewswire

    Marrone Bio Innovations allowed key claims by U.S. Patent and Trademark Office for Grandevo® WDG

    Marrone Bio Innovations Inc. (MBII) (MBI), a leading developer of biological crop protection and plant health solutions, has received a notice of allowance from the U.S. Patent and Trademark Office for key claims covering the composition and method of manufacturing for Grandevo WDG, an MBI developed microbial-based bioinsecticide. A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office after a patent examiner has decided to issue the requested patent.

  • Zacks Small Cap Research

    MBII: Recent study of impact of Venerate and Grandevo on almond tree pests confirms the efficacy of dual treatments

    Marrone Bio Innovations has released the results of a 2018 study on the impact of Venerate® XC and Grandevo® WDG on almond pests. The addition of Venerate® XC reduced the total nut damage due to navel orangeworm, Amyelois transitella, by an additional two percent. This pest has developed a resistance to a number of conventional chemical pesticides.